Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Yeo, Hyeon-Gua; b; 1 | Lee, Youngjeona; 1 | Jeon, Chang-Yeopa; c; 1 | Jeong, Kang-Jina | Jin, Yeung Baea | Kang, Philyonga | Kim, Sun-Uka | Kim, Ji-Sua | Huh, Jae-Wona | Kim, Young-Hyuna | Sim, Bo-Woonga | Song, Bong-Seoka | Park, Young-Hoa | Hong, Yonggeund | Lee, Sang-Raea; * | Chang, Kyu-Taea; b; *
Affiliations: [a] National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea | [b] Department of Functional Genomics, University of Science and Technology, Daejeon, Republic of Korea | [c] Department of Biomedical Engineering, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea | [d] Department of Rehabilitation Science, Graduate School of Inje University, Gimhae, Republic of Korea
Correspondence: [*] Correspondence to: Kyu-Tae Chang, PhD, National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Chungwon-gun, Chungbuk 363-883, Republic of Korea. Tel.: +82 43 240 6300; Fax: +82 43 240 6309; E-mail: [email protected]
Correspondence: [*] Correspondence to: Sang-Rae Lee, DVM, PhD, National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.Tel.: +82 43 240 6322; Fax: +82 43 240 6309; [email protected]
Note: [1] These authors contributed equally to this work.
Abstract: In line with recent findings showing Alzheimer’s disease (AD) as an insulin-resistant brain state, a non-transgenic animal model with intracerebroventricular streptozotocin (icv-STZ) administration has been proposed as a representative experimental model of AD. Although icv-STZ rodent models of AD have been increasingly researched, studies in non-human primate models are very limited. In this study, we aimed to characterize the cerebral damage caused by icv-STZ in non-human primates; to achieve this, three cynomolgus monkeys (Macaca fascicularis) were administered four dosages of STZ (2 mg/kg) dissolved in artificial cerebrospinal fluid and another three controls were injected with only artificial cerebrospinal fluid at the cerebellomedullary cistern. In vivo neuroimaging was performed with clinical 3.0 T MRI, followed by quantitative analysis with FSL for evaluation of structural changes of the brain. Immunohistochemistry was performed to evaluate cerebral histopathology. We showed that icv-STZ caused severe ventricular enlargement and parenchymal atrophy, accompanying amyloid-β deposition, hippocampal cell loss, tauopathy, ependymal cell loss, astrogliosis, and microglial activation, which are observed in human aged or AD brain. The findings suggest that the icv-STZ monkey model would be a valuable resource to study the mechanisms and consequences of a variety of cerebral pathologies including major pathological hallmarks of AD. Furthermore, the study of icv-STZ monkeys could contribute to the development of treatments for age- or AD-associated cerebral changes.
Keywords: Alzheimer’s disease, animal model, brain, monkey, streptozotocin
DOI: 10.3233/JAD-143222
Journal: Journal of Alzheimer's Disease, vol. 46, no. 4, pp. 989-1005, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]